Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Technology may expedite operations, but the absence of the human element could cost dearly.

All Systems Slow

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

Industry experts discuss formulation and technical challenges in multilayer tablet manufacture.

Multilayer-Tablet Technology

Multilayer tablets can be challenging, but meeting regulatory expectations is crucial. We speak with Vilayat Sayeed from the FDA, to find out more about the critical factors that need to be fully understood.

Multilayer Tablets: Critical Factors To Consider

Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries. Pneumococcal disease can lead to pneumonia, meningitis, and sepsis, and is one of leading causes of death in children under the age of five in developing countries.

Pfizer, GSK Commit to Supplying Developing World with Vaccines

AstraZeneca Acquires Chinese Generic-Drug Company; Takeda Makes Management Changes; and More.

Week of Dec. 26, 2011: AstraZeneca Acquires Chinese Generic-Drug Company; Takeda Makes Management Changes; and More

Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries.

Pfizer, GSK commit supplying developing world with vaccines

Last week, the US Department of Health and Human Services and Novartis Vaccines and Diagnostics dedicated a manufacturing plant that can create influenza vaccine using cultured animal cells instead of the conventional expression system of fertilized eggs.

HHS and Novartis Dedicate First Cell-Based Flu Vaccine Plant in US

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Samsung and Biogen Idec agreed to invest $300 million to establish a joint venture to develop, manufacture, and market biosimilars. The deal is Samsung's latest effort to strengthen its position in biosimilars.

Biogen Idec, Samsung Form Biosimilars Joint Venture

Amy Ritter was Scientific Editor, BioPharm International.

On Dec. 6, 2011, FDA announced that a public meeting will be held on Dec. 16, 2011 to discuss recommendations for a user fee program for biosimilar biological products for fiscal years 2013–2017.

FDA Announces Public Meeting to Discuss Biosimilar User Fees

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Biosimilar manufacturers need better expression systems and analytical tools to compete.